These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38914172)

  • 1. Neurochemical changes in the progression of Huntington's disease: A meta-analysis of in vivo
    Jing Y; Dogan I; Reetz K; Romanzetti S
    Neurobiol Dis; 2024 Sep; 199():106574. PubMed ID: 38914172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal metabolite changes in Huntington's disease during disease onset.
    van den Bogaard SJ; Dumas EM; Teeuwisse WM; Kan HE; Webb A; van Buchem MA; Roos RA; van der Grond J
    J Huntingtons Dis; 2014; 3(4):377-86. PubMed ID: 25575959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longitudinal study of magnetic resonance spectroscopy Huntington's disease biomarkers.
    Sturrock A; Laule C; Wyper K; Milner RA; Decolongon J; Dar Santos R; Coleman AJ; Carter K; Creighton S; Bechtel N; Bohlen S; Reilmann R; Johnson HJ; Hayden MR; Tabrizi SJ; Mackay AL; Leavitt BR
    Mov Disord; 2015 Mar; 30(3):393-401. PubMed ID: 25690257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurochemical correlates of caudate atrophy in Huntington's disease.
    Padowski JM; Weaver KE; Richards TL; Laurino MY; Samii A; Aylward EH; Conley KE
    Mov Disord; 2014 Mar; 29(3):327-35. PubMed ID: 24442623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease.
    Sturrock A; Laule C; Decolongon J; Dar Santos R; Coleman AJ; Creighton S; Bechtel N; Reilmann R; Hayden MR; Tabrizi SJ; Mackay AL; Leavitt BR
    Neurology; 2010 Nov; 75(19):1702-10. PubMed ID: 21060093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain metabolite alterations and cognitive dysfunction in early Huntington's disease.
    Unschuld PG; Edden RA; Carass A; Liu X; Shanahan M; Wang X; Oishi K; Brandt J; Bassett SS; Redgrave GW; Margolis RL; van Zijl PC; Barker PB; Ross CA
    Mov Disord; 2012 Jun; 27(7):895-902. PubMed ID: 22649062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal evaluation of proton magnetic resonance spectroscopy metabolites as biomarkers in Huntington's disease.
    Lowe AJ; Rodrigues FB; Arridge M; De Vita E; Johnson EB; Scahill RI; Byrne LM; Tortelli R; Heslegrave A; Zetterberg H; Wild EJ
    Brain Commun; 2022; 4(6):fcac258. PubMed ID: 36382217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creatine supplementation lowers brain glutamate levels in Huntington's disease.
    Bender A; Auer DP; Merl T; Reilmann R; Saemann P; Yassouridis A; Bender J; Weindl A; Dose M; Gasser T; Klopstock T
    J Neurol; 2005 Jan; 252(1):36-41. PubMed ID: 15672208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontal lobe
    Chen Q; Boeve BF; Tosakulwong N; Lesnick T; Brushaber D; Dheel C; Fields J; Forsberg L; Gavrilova R; Gearhart D; Haley D; Gunter JL; Graff-Radford J; Jones D; Knopman D; Graff-Radford N; Kraft R; Lapid M; Rademakers R; Syrjanen J; Wszolek ZK; Rosen H; Boxer AL; Kantarci K
    Neurology; 2019 Aug; 93(8):e758-e765. PubMed ID: 31315971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional magnetic resonance imaging of working memory in Huntington's disease: cross-sectional data from the IMAGE-HD study.
    Georgiou-Karistianis N; Stout JC; Domínguez D JF; Carron SP; Ando A; Churchyard A; Chua P; Bohanna I; Dymowski AR; Poudel G; Egan GF
    Hum Brain Mapp; 2014 May; 35(5):1847-64. PubMed ID: 23913754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy.
    Jenkins BG; Koroshetz WJ; Beal MF; Rosen BR
    Neurology; 1993 Dec; 43(12):2689-95. PubMed ID: 8255479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploratory 7-Tesla magnetic resonance spectroscopy in Huntington's disease provides in vivo evidence for impaired energy metabolism.
    van den Bogaard SJ; Dumas EM; Teeuwisse WM; Kan HE; Webb A; Roos RA; van der Grond J
    J Neurol; 2011 Dec; 258(12):2230-9. PubMed ID: 21614431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistent neurodegeneration and its association with clinical progression in Huntington's disease: a coordinate-based meta-analysis.
    Dogan I; Eickhoff SB; Schulz JB; Shah NJ; Laird AR; Fox PT; Reetz K
    Neurodegener Dis; 2013; 12(1):23-35. PubMed ID: 22922585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR-spectroscopic findings in juvenile-onset Huntington's disease.
    Reynolds NC; Prost RW; Mark LP; Joseph SA
    Mov Disord; 2008 Oct; 23(13):1931-5. PubMed ID: 18759332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical correlation of striatal 1H MRS changes in Huntington's disease.
    Sánchez-Pernaute R; García-Segura JM; del Barrio Alba A; Viaño J; de Yébenes JG
    Neurology; 1999 Sep; 53(4):806-12. PubMed ID: 10489045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal change in white matter microstructure in Huntington's disease: The IMAGE-HD study.
    Poudel GR; Stout JC; Domínguez D JF; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
    Neurobiol Dis; 2015 Feb; 74():406-12. PubMed ID: 25497085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington's disease mice.
    van Dellen A; Welch J; Dixon RM; Cordery P; York D; Styles P; Blakemore C; Hannan AJ
    Neuroreport; 2000 Nov; 11(17):3751-7. PubMed ID: 11117485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity in 1H-MRS profiles of presymptomatic and early manifest Huntington's disease.
    Reynolds NC; Prost RW; Mark LP
    Brain Res; 2005 Jan; 1031(1):82-9. PubMed ID: 15621015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar Progression of Morphological and Metabolic Phenotype in R6/2 Mice with Different CAG Repeats Revealed by In Vivo Magnetic Resonance Imaging and Spectroscopy.
    Sawiak SJ; Wood NI; Morton AJ
    J Huntingtons Dis; 2016 Oct; 5(3):271-283. PubMed ID: 27662335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurochemical correlates of synapse density in a Huntington's disease mouse model.
    Zarate N; Gundry K; Yu D; Casby J; Eberly LE; Öz G; Gomez-Pastor R
    J Neurochem; 2023 Jan; 164(2):226-241. PubMed ID: 36272099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.